Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- Check6 days agoChange DetectedAdded: Revision: v3.3.3 and removed: HHS Vulnerability Disclosure and Revision: v3.3.2. The changes pertain to site-wide release notes/footer and do not affect the Study Details content or its purpose.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedA notice about government funding status and potential delays at the top of the page was removed. The rest of the study details and navigation appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedNo substantive changes to the study details were detected; the page content remains the same aside from minor UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check85 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior version tag v3.1.0 was removed.SummaryDifference4%

- Check92 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.